Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials
Open Access
- 28 June 2020
- journal article
- review article
- Published by MDPI AG in Nanomaterials
- Vol. 10 (7), 1267
- https://doi.org/10.3390/nano10071267
Abstract
There have been efforts to develop physiologically based pharmacokinetic (PBPK) models for nanomaterials (NMs). Since NMs have quite different kinetic behaviors, the applicability of the approaches and techniques that are utilized in current PBPK models for NMs is warranted. Most PBPK models simulate a size-independent endocytosis from tissues or blood. In the lungs, dosimetry and the air-liquid interface (ALI) models have sometimes been used to estimate NM deposition and translocation into the circulatory system. In the gastrointestinal (GI) tract, kinetics data are needed for mechanistic understanding of NM behavior as well as their absorption through GI mucus and their subsequent hepatobiliary excretion into feces. Following absorption, permeability (Pt) and partition coefficients (PCs) are needed to simulate partitioning from the circulatory system into various organs. Furthermore, mechanistic modelling of organ- and species-specific NM corona formation is in its infancy. More recently, some PBPK models have included the mononuclear phagocyte system (MPS). Most notably, dissolution, a key elimination process for NMs, is only empirically added in some PBPK models. Nevertheless, despite the many challenges still present, there have been great advances in the development and application of PBPK models for hazard assessment and risk assessment of NMs.Keywords
This publication has 155 references indexed in Scilit:
- Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and DevelopmentCPT: Pharmacometrics & Systems Pharmacology, 2013
- Dynamics of Nanoparticle-Protein Corona Complex Formation: Analytical Results from Population Balance EquationsPLOS ONE, 2013
- Factoring-in agglomeration of carbon nanotubes and nanofibers for better prediction of their toxicity versus asbestosParticle and Fibre Toxicology, 2012
- Physiologically Based Pharmacokinetic Modeling: Methodology, Applications, and Limitations with a Focus on Its Role in Pediatric Drug DevelopmentJournal of Biomedicine and Biotechnology, 2011
- Development of appropriate equations for physiologically based pharmacokinetic modeling of permeability-limited and flow-limited transportJournal of Pharmacokinetics and Pharmacodynamics, 2011
- Tissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the ratToxicology and Applied Pharmacology, 2011
- Rapid translocation of nanoparticles from the lung airspaces to the bodyNature Biotechnology, 2010
- Physiologically Based Pharmacokinetics of Molecular Imaging Nanoparticles for mRNA Detection Determined in Tumor-Bearing MiceOligonucleotides, 2010
- Kupffer cells are central in the removal of nanoparticles from the organismParticle and Fibre Toxicology, 2007
- Renal clearance of quantum dotsNature Biotechnology, 2007